Abstract The aim of this study was to propose and validate a new unified method for testing dissolution rates of bioactive glasses and their variants, and the formation of calcium phosphate layer formation on their surface, which is an indicator of bioactivity. At present, comparison in the literature is difficult as many groups use different testing protocols. An ISO standard covers the use of simulated body fluid on standard shape materials but it does not take into account that bioactive glasses can have very different specific surface areas, as for glass powders. Validation of the proposed modified test was through round robin testing and comparison to the ISO standard where appropriate. The proposed test uses fixed mass per solution volume ratio and agitated solution. The round robin study showed differences in hydroxyapatite nucleation on glasses of different composition and between glasses of the same composition but different particle size. The results were reproducible between research facilities. Researchers should use this method when testing new glasses, or their variants, to enable comparison between the literature in the future.
Larry Hench, had the 45S5 composition (46.1 mol% SiO 2 , 26.9 mol% CaO, 24.4 mol% Na 2 O, 2.6 mol% P 2 O 5 ) and was termed Bioglass Ò [12] . In vivo studies showed it to bond to bone and stimulate more bone growth than particles of synthetic hydroxyapatite and apatite-wollastonite glass-ceramics [27] . The mechanism of bone bonding is through the formation of a surface layer of hydroxycarbonate apatite (HCA), which is similar to the mineral component of bone [35] . The HCA layer forms following cation exchange from the glass with protons from body fluid, which leaves a poorly connected silica rich layer [7] . Calcium phosphate precipitates on the silica rich layer and crystallises to form HCA [12] . The Bioglass composition is commercially available, in particulate form, as a synthetic bone graft NovaBone TM (NovaBone Products LLC, Jacksonville FL) and has been implanted in more than 1 million patients. A finer particulate form of the same glass is now also used to treat dental hypersensitivity by incorporation into toothpaste [8] . Since its development, there has been a lot of work investigating the effect of glass composition, morphology (particle vs. monolith vs. fibre vs. scaffold) and glass type (melt vs. sol-gel) on rate of dissolution and apatite formation in vitro. However many of the research articles describing the work present different protocols for testing the glass dissolution and apatite forming ability, making it difficult for the reader to make comparisons.
For this reason, an ISO standard has been proposed for the testing of the apatite forming ability of medical implants (ISO / FDIS 23317/, Implants for surgery In vitro evaluation for apatite-forming ability of implant materials) [22] . However this test was designed for testing bioceramic or glass-ceramic coatings on metal substrates or for monolithic (disc) shaped samples. It does not translate well to powder or porous bioactive glasses. There are two main reasons for this: (i) the ISO test fixes the surface area to solution volume ratio when comparing samples; (ii) the test is static. Keeping surface area constant allows comparison between samples of different compositions but does not allow comparison between samples of the same composition but different morphologies. Surgeons are likely to use such materials for filling a bone defect of a certain volume, so fixing surface area would not be suitable for the development of bioactive glass fibres and porous scaffolds [5, 10, 15, 28] . Sol-gel glasses also have specific surface areas several orders of magnitude higher than melt-derived glasses, for the same particle size, due to their inherent nanoporosity. Therefore fixing surface area to compare dissolution of a sol-gel and a melt-derived glass would not even be possible, and would not be a valid test.
The aim is not to develop a method for predicting whether materials will form a bond with bone. As reported previously, in vitro conditions cannot match those in vivo, and a simulated body fluid does not exist that exactly matches those of the human body [3, 31] . Instead, the aim is to develop a facile test that can be used in most research laboratories around the world and allow comparison of dissolution rates and apatite nucleation. The test is a modification of the ISO standard, which uses simulated body fluid [17] . The proposed test agreed upon by Technical Committee 4 (TC04) of the International Commission on Glass (ICG) and will be referred to here as the TC04 method. This test was validated through a round robin study in eight different laboratories in seven countries to ensure reproducibility and to compare to the ISO standard. High purity, commercial glasses were used that were produced under Good Manufacturing Practice (GMP), 5 melt and 1 sol-gel derived. NovaBone (NB) is the commercial form of Bioglass, which has a broad particle size distribution. BonAlive TM (BA, Vivoxid, Turku, Finland) is another melt-derived particulate with a different ratio of its component oxides [25] . 13-93 is a composition that was originally designed for fibre drawing, as it is difficult to pull Bioglass fibres without the glass crystallising [4] . More recently it has been used to produce scaffolds for bone regneration [10] . StonBone has a similar composition to Bioglass, except that some of the calcium was substituted with strontium [24] . TheraGlass (TheraGlass Ltd., London, UK) is a binary sol-gel derived glass [32] . Details of the glass compositions are given in Table 1 .
Materials and Methods

The bioactive glasses
Commercial samples of bioactive glasses were used to ensure all groups had reproducible samples. All the different elemental compositions are details in Table 1 . BonAlive (Turku, Finland) has a particle size range of 45-90 lm (BA). Mo-Sci (Rolla, MO) kindly produced 45S5 Bioglass (BG) and 13-93 to the same particle size range. Sr-Bioglass (Sr-BG) of the same particle size range was provided by RepRegen Ltd. (London, UK). A sol-gel derived bioactive 
Surface area and density measurement
Nitrogen sorption was used to estimate the surface area of the glass powders (Autosorb AS6, QuantaChrome). In order to remove any trace of moisture, samples were degassed at 150°C for 8 h before analysis (Degasser, Quantachrome). Specific surface areas were calculated by fitting the first seven points (relative pressures of 0.05-0.3) of the adsorption branch of the isotherm to the BET equation [6] . Skeletal density was determined by helium pycnometry (Ultrapycnometer 1000, QuantaChrome) on glasses, with the use of a known mass of powder previously dried at 80°C for 24 h.
Particle size analysis
Particle sizes were measured using a laser diffraction (Malvern Mastersizer 2000 equipped with a Hydro 2000 SM dispersion unit). The volume average particle diameters D quoted are obtained from at least five repeat runs. d(0,5) is the diameter under which 50 % of the particles fall.
Bioactivity tests
Simulated body fluid preparation
Simulated body fluid (SBF) was prepared according to Kokubo's method [17] . Reagents (Table 2) were provided by Sigma-Aldrich UK and used as received without further purification. To produce 1 L of SBF, 700 mL of deionized (DI) water was placed in a 1 L polypropylene beaker and set at 37 ± 1.0°C in a water bath. The solution was continuously stirred throughout. The reagents were slowly added to the DI water in the order given in Table 2 with an accuracy of AE0:5 mg. The pH was monitored to avoid any rapid increase, which would cause precipitation. Once the reagents were mixed, the SBF was transferred to a 1 L volumetric flask and filled to the mark with DI water once cooled at RT. SBF was stored at 37°C and used within 2 days. The pH was adjusted to 7.4 before use at 37°C.
TC04 method: Bioactivity of powders based on concentration
Bioactive glass powders were immersed in SBF using a ratio of 75 mg glass to 50 mL SBF in an airtight polyethylene container. Dissolution vessels were placed in an incubating orbital shaker held at 37°C, agitated at 120 rpm. The pH and temperature of the media was verified before use. The samples were incubated for 8 different time points: 4 h, 8 h, 24 h, 72 h, 1 week, 2 weeks, 3 weeks and 4 weeks. At the end of each time period, the sample was removed from the incubator and the solids were collected by filtration (particle retention 5-13 lm). The powder was immediately washed with DI water and subsequently with acetone to terminate any reaction. Each sample was run in triplicate. The filtered solution was collected to determine the ion concentrations using an inductively coupled plasma (ICP) analysis; the pH of the solution was also measured. The same protocol was applied to SBF alone as a control.
ISO / FDIS 23317: Bioactivity of powders based on surface area
Bioactive glass powders were immersed in SBF using a fixed volume to surface area ratio: V SBF ¼ 100 Â S a;glass where V SBF is the volume of SBF used and S a;glass the apparent surface area of the specimen. Here, the mass of glass particles used for each composition was calculated for 100 mL of SBF. The rest of the protocol was the same as previous test except that samples were not agitated. Each sample was run in triplicate. This ISO standard was designed for solid disc shaped samples, so discs of 13-93 composition were also tested.
Post-test characterization
The details of the equipments described below are specific of the plotted data. however, they are representative examples of all of the results collected by similar means in the different laboratories.
Inductively coupled plasma-atomic emission spectroscopy
Concentrations in solution were measured with a Thermo Scientific iCAP 6300 Duo inductively coupled plasmaoptical emission spectrometer (ICP-OES) with auto sampler. Sample solutions were prepared by diluting the samples by a factor of 10 with analytical grade 2 M HNO 3 .
Mixed standards of silicon, phosphorus, calcium, sodium and potassium were prepared at 0, 2, 5, 20 and 40 lgÁmL
for the calibration curve. Silicon and phosphorus were measured in the axial direction of the plasma flame whereas calcium, sodium and potassium were measured in the radial direction.
Fourier transform infrared spectroscopy
KBr pellets containing bioactive glass powder were prepared under 8 tons of pressure at a ratio of 2 wt% of sample to KBr. Fourier transform infrared spectroscopy (FTIR) was performed using a Thermo Nicolet Nexus 670 FTIR purged with nitrogen in transmission mode with a spectral resolution of 2 cm À1 from 4,000 to 400 cm À1 . Spectra were collected as mean of 32 scans and plotted as adsorption.
X-ray diffraction
X-ray diffraction (XRD) patterns of glasses before and after immersion in SBF were recorded using a Panalytical Xpert Pro MPD. The radiation source was a Ni-filtered Cu j a . Diffraction was measured continuously from 6°to 70 2h, with a step size of 0.026 and a time per step of 100 s.
Scanning electron microscopy
Field emission gun scanning electron microscopy (FEG-SEM) was performed on a JEOL 7100 using a gun voltage of 15 kV and a working distance of 10 mm. Samples were mounted on double sided carbon tape and coated with gold.
Statistics
Where required, sample sets were statistically tested against a null hypothesis using a t test implemented on Matlab R2013b (function t-test 2). Samples were considered paired with equal size and unequal variance. The level of statistical significance was fixed at 0.05.
Results and discussion
Pre-test characterisation
Each company sized their particles by sieving, using sieves of 90 and 45 lm, with the exception of NovaBone, who used sieves of 90 and 710 lm. As dissolution is dependent on surface area, it was important to measure the actual particle size distributions (refer to Supplementary Figure) [14] . Table 3 shows the d 50 which is the diameter under which 50 % of the particles fall and D which is an arithmetic volume average of the particle equivalent diameters. The d 50 and D values were similar (within 5 lm) for all powders, except NovaBone. This means that all glasses except NovaBone had Gaussian-like particle size distributions. NovaBone had a trimodal distribution with modes at 0:4; 11:5 and 208:9 lm. All meltderived powders with the specified ranges of 45-90 lm also had similar values d 50 and D values 73-87 lm. TheraGlass particles were smaller (D of 45:5 lm), which is likely to be due to their inherent nanoporosity, making grinding easier.
The skeletal density, q s , of all the glasses where similar at approximately 2.7 g cm -3 (see Table 3 ).
Limitation of ISO / FDIS 23317 for bioactive glasses
This method was designed only for solid, regular geometric shaped samples, such as dics or tiles and was never designed for glass powders or porous materials. This leads to the first problem with carrying out the bioactivity testing with the ISO standard; the measurement of the surface area of the glass powders. Consistent measurement of specific surface area (SSA) for glass particles exceeding 30 lm in size is difficult. Two methods were used: (i) combination of the particle size distribution and the density of the particles; (ii) gas adsorption using the BET method [1] . The first method incorrectly assumes that all particles were spherical, underestimating the surface area due to the angularity of ground glass powders (Table 3) . It also did not take into account the intrinsic nanoporosity of the sol-gel derived glass (TG). Nitrogen sorption did take the porosity into account and the data for TG were in good agreement with the literature [19] . However, the BET SSA values for the melt derived glasses were small, ranging from 0.20 to 0:36 m 2 g À1 , which are below the accurate detection limits of 1 m 2 g À1 [20, 34] . Once SSA was obtained, the quantity of glass needed to perform the ISO standard in 100 mL of SBF was calculated using BET SSA (Table 3) . Values for the melt-derived glasses varied from 2.78 to 5 mg for 100 mL of SBF. However, for the sol-gel derived glass the amount of glass was impractical (0.012 mg per 100 mL of SBF). Therefore, only the melt-derived glasses were tested with the ISO standard.
Bioactivity of commercially available bioactive glasses
The TC04 method, which fixes the mass of glass in SBF, was compared to the ISO test, which used a consistent surface area. For both tests, the concentration of silicon, calcium and phosphorus and the pH value varied over the length of the test compared with SBF alone (Fig. 1) . The rise in pH was due to the cation exchange, predominantly of Na þ and Ca 2þ from the glasses with protons from the solution [7] . Using the TC04 method, the pH level after 4 weeks increased with the amount of cations present originally in the glass composition. There was no such pattern observed with the ISO standard. This is due to the low mass of meltderived glass powder in the ISO standard test, releasing such a low concentration of cations that it did not disturb the buffering capacity of SBF. To test this hypothesis, a disc of 13-93 glass was tested by the ISO test. The SSA of the disc was 0:00465 m 2 g À1 , so the 0.082 g was immersed in 64 mL of SBF. This led to a pH of 7.71 at 4 weeks, with [Ca] of 97 ± 2.7 lgÁmL -1 , due the higher mass of glass. The silica 57.6 ± 1.4 lgÁmL -1 and calcium release from the disc were similar to that of the powders in the TC04 method. The difference was the phosphorus depletion in the SBF was slower for the disc in the ISO standard compared to the powder in the TC04 method, as the surface area of the powder was greater, which is likely to enhance HCA formation.
In the TC04 test, the pH rise for TG was in the same order as that for NB after 4 weeks of dissolution (pH 8.05 and 8.09 respectively, P [ 0.5). However, TG has no Na 2 O and a slightly more CaO (30 mol%) than NB (24.4 mol% Na 2 O and 26.9 mol% CaO), which indicated that the intrinsic nanoporosity of TG enhanced its dissolution [2, 33] . In addition sol-gel glasses have lower network connectivity (number of bridging oxygen bonds per silicon atom) than their nominal composition suggests, due to the presence of Si-OH groups, where H þ ions act as additional network modifiers [19] .
The soluble silica release profiles for all compositions showed an increase in the concentration, following a negative exponential trend, levelling off after 3 days of dissolution. However, the [Si] profiles differed between the two tests. In the TC04 test, the soluble silica released at different rates depending on glass compositions (see Supplementary Table 1 ), but the final concentration after 4 weeks was statically equivalent among all glasses ð½Si 4weeks ¼ 60:2 lgÁmL À1 ; P [ 0:25Þ. However, the amount of soluble silica released using the ISO standard was directly proportional to the initial mass of glass (Supplementary Figure II) . This would falsely imply that 13-93 degraded faster than NB as both glasses had theoretically the same surface exposed to the media. However, there was a greater mass of 13-93 initially immersed in the SBF (11.11 mg) than NB (2.78 mg), due to the difference in the measured surface area between 13 and 93 and NB. Due to the inaccuracy of the BET method for these particles, more 13-93 glass was immersed in the SBF, causing the absolute amount of silica release to be higher. 13-93 is known to have a higher network connectivity than 45S5 making the glass more resistant to degradation (Table 3 ) [16] .
The concentrations of calcium and phosphorus in SBF were also monitored as a function of time. A decrease in their level is usually considered as a good indicator of calciumphosphate precipitation [14] . SBF contains approximately 90 lgÁmL -1 of calcium ions and 30 lgÁmL -1 of phosphorus. The release of calcium followed the trend of the silica release over the first day of dissolution when using the TC04 method, showing a degradation of the glass. Subsequently, for glasses with the lower amounts of calcium in their composition (13- . The concentration of phosphorus decreased for all compositions regardless of the method used. However, the TC04 method exhibited a more defined and more rapid decrease in [P] . As an example, 13-93 had an immediate decrease in [P] approaching 0:5 lgÁmL À1 at 1 week, using the TC04 method, whereas [P] started to decline only after 2 weeks using the ISO standard method. Again, this could be due to a lower mass of glass present in the ISO standard, but could also be due to the agitation in the TC04 test [29] . A concern of using SBF is that once P is depleted from the SBF, subsequent changes to samples and solutions are less representative of a 'biomaterial' response to physiological solution.
Post-test surface characterisation
Calcium-phosphate nucleates on the surface of the different bioactive glasses, all the participants of this round robin test were asked to investigate surface chemistry changes using FTIR and XRD. Due to the small mass of glass powder used in the ISO test, only FTIR analysis was carried out on these solids, which are given in Supplementary information ( Figure SIII) . Figure 2 shows the FTIR spectra obtained after 4 weeks immersion in SBF (TC04 method). The mechanism of hydroxyapatite formation is known to involve silica-rich layer formation at the glass surface, following cation exchange, containing Si-OH groups that act as nucleation sites for amorphous calcium-phosphate [18, 26] . The local pH increase promotes calcium-phosphate (Ca-P) crystallisation where the tetrahedral PO À3 4 exhibits sharp IR absorptions at 565 and 605 cm À1 , characteristic of P-O bending, and at 1; 030 cm À1 , characteristic of P-O stretching [30, 36] . Spectra collected from BG showed the P-O bending vibration bands after 24 h of immersion in SBF (Fig. 2a) [23, 35] . The precipitation of pure hydroxyapatite (HA) is less likely to happen in SBF as it is saturated with respect of slightly carbonated apatite, where the orthophosphates are substituted by carbonates in the crystal lattice [9] . Only TG was found to nucleate Ca-P crystal at a similar (fast) rate to BG. Sol-gel derived glasses, due to their higher surface area, the abundance of OH groups and low network connectivity are better inducers of nucleation than melt derived glasses of similar compositions [18, 33] . All the other glasses were found to nucleate apatite more slowly (Fig. 2b) . Time points at which apatite did nucleate on the glasses are discussed in the results of the round robin study section below. Something to consider with the FTIR spectra is that the P-O bending bands, at 565 and 605 cm 1 are not characteristic to HA or HCA, but they do indicate the presence of orthophosphate lattices [11] .
Therefore, to confirm the nature of the newly crystalline phase formed at the surface the different glasses, X-ray diffraction was carried out as shown in Fig. 3 . XRD results were in good agreement with FTIR with crystalline peaks observed at 24 h for BG, confirming abundant HCA formation on the surface of the glass, with sharp peak at 2h % 26 and 32
and a positive correlation of the other peaks with external reference (ICSD 01-084-1998). The bioactivity of BG reported here was in agreement with literature [14] . However, a mixture of HCA and calcite (calcium carbonate, ICSD 52151) was found on the surface of TheraGlass, highlighting the importance and the complementarity of XRD with FTIR. This observation had already been made by Martinez et. al. who investigated the bioactivity of CaO-SiO 2 binary sol-gel (a) (b) glasses [21] . For their bioactivity test, disks were produce of the dimension recommended by the ISO method, overlooking the higher surface area of the sol-gel glass [17] . Interestingly, crystalline phases were sharper and more defined using the TC04 test proposed here, due to the increase in exposed surface to the media between disk and powder. Finally, change in morphology due to the dissolution and precipitation of phosphate compounds on the different glasses was analysed by electron microscopy. The surfaces of the bioactive glasses were found to be smooth and dense before immersion in SBF. However, large needle-like structures characteristic to HA were found to cover almost the entire surface of BG and TG after 24h of immersion [13] . At the same time point, NB was found with a mixture of amorphous calcium phosphate and HCA, corroborating data obtained by XRD and FTIR.
3.5 Round robin outcomes Figure 5 summarises the results obtained across the 8 institutions that participated in this round robin test. Grey shading shows HCA was detected by FTIR and XRD, with the fraction of participants obtaining the same result given in parentheses. The y symbol indicates where the HCA appeared at the same time point in the TC04 and ISO test, i.e. where the tests agreed according to post test surface analysis. Note that only six out of eight institutions investigated the bioactivity of BA. Using the TC04 method, the direct effect of the particle size on the bioactivity could be seen. BG, which has a smaller particle size range than NB, nucleated more HCA an earlier time point than NB. The time at which HCA was found on the surface of the different glasses using FTIR and XRD was consistent among the participants. BG and TG were found to be the faster to nucleate HCA, in 24 h, followed by Sr-BG, NB and BA, in 72 h. 13-93 was the slowest with a nucleation time of 1 week. Nucleation of HCA on the 13-93 powder occurred 1 week earlier in the TC04 tests than in the ISO , TG was not tested using the ISO method standard. However, the time points were discrete and 1 week apart, as the surface analysis used here was not continuous. This study therefore also highlights the importance of using ICP analysis to study dissolution and apatite formation of bioactive glasses. The change in phosphate concentration as a function of time can give more accurate information on the precipitation of calcium phosphate. The time point where phosphate concentration drops rapidly can be correlated to calcium phosphate precipitation on the glass surface. ICP can be used to refine the window of time in which HCA formation occurs. HCA formation was different for different glass compositions due to the change in network connectivity (NC) of the glasses [16] . NC increases with increased silica content (e.g. BA compared to BG), but also with the introduction of network intermediates. 13-93 contains magnesium, of which a proportion is thought to act as an intermediate [37] . The TC04 test is a relatively simple test that distinguishes between different glasses and should be employed by groups wanting to test new bioactive glasses, or their variants, which will enable comparison between the literature in the future.
Conclusion
The aim of this study was to suggest a method for testing bioactive glasses, particularly those of high surface area, and to verify the reproducibility of the method by a large number of research groups working in the field. The protocol was a modified version of the ISO standard for testing apatite formation based on sample mass to liquid ratio. Comparison with the ISO standard showed that the method proposed here was more appropriate for bioactive glasses, particularly for particles or glasses with high surface area.
